Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
The anion gap as a predictive tool for morbidity and mortality147
Deep learning algorithms and Raman spectroscopy in the clinical laboratory setting72
Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review61
Data analytics for error detection in clinical laboratories48
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath44
Lipoprotein(a): a genetically determined risk factor for Cardiovascular disease41
Machine learning-based error detection in the clinical laboratory: a critical review40
Human telomere length detected by quantitative fluorescent in situ hybridization: overlooked importance and application37
Transthyretin mutagenesis: impact on amyloidogenesis and disease36
Copeptin as a surrogate marker for arginine vasopressin: analytical insights, current utility, and emerging applications33
The therapeutic relevance of the Kallikrein-Kinin axis in SARS-cov-2-induced vascular pathology33
Evaluating thyroid function in pregnant women31
Clinical utility of human epididymis protein 428
Cardiovascular disease lipids and lipoproteins biomarker standardization27
Beyond newborn screening: the role of reverse cascade testing in familial disease detection26
Guidance for securing approvals for new biomarkers: from discovery to clinical implementation25
KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker25
Development of next-generation reference interval models to establish reference intervals based on medical data: current status, algorithms and future consideration22
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases22
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-1922
Challenges of insulin-like growth factor-1 testing19
Analytical and clinical considerations of synovial fluid calprotectin in diagnosing periprosthetic joint infections19
Association of inflammatory biomarkers with morbidity and mortality risk in patients with peripheral artery disease: a systematic review and ­meta-analysis19
Emerging applications of machine learning in genomic medicine and healthcare18
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future17
Therapeutic biomarkers in metastatic castration-resistant prostate cancer: does the state matter?16
Using a systematic approach to strategic innovation in laboratory medicine to bring about change16
Pleural fluid biomarkers for the diagnosis and management of malignant pleural effusions: a clinical review16
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders15
The intersection of the laboratory and transgender care15
General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis14
The urocortin peptides: biological relevance and laboratory aspects of UCN3 and its receptor14
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review13
Pathogenicity and virulence of human T lymphotropic virus type-1 (HTLV-1) in oncogenesis: adult T-cell leukemia/lymphoma (ATLL)13
Guidelines for diagnosing and differentiating infection with antifungal-resistant Trichophyton indotineae from other dermatophytoses13
Insight into metabolic dysregulation of polycystic ovary syndrome utilizing metabolomic signatures: a narrative review12
DNA/RNA-based electrochemical nanobiosensors for early detection of cancers12
Advances in internal quality control12
Point of care blood glucose devices in the hospital setting12
Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization12
Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?12
Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer12
The multidimensional value of natriuretic peptides in heart failure, integrating laboratory and clinical aspects12
0.018811941146851